A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...
British scientists have hailed the US approval of a new drug for schizophrenia, saying it “has the potential to change the ...
The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia,  the FDA announced Thursday.
The FDA has approved a first-in-class antipsychotic that targets cholinergic receptors without blocking dopamine receptors.